The Global Leader in Recombinant Technology

Sino Biological is an internationally recognized reagent supplier and contract research organization. Sino Biological's core technology platform is its in-house developed mammalian cell-based recombinant expression system. The system employs a range of proprietary reagents and processes, enabling high-efficient production of antigens and antibodies. The current catalog includes 10,000+ recombinant antigens, along with 2,000+ unique clones of monoclonal antibodies.
Sino Biological is dedicated to supporting SARS-COV-2 research. The company’s antibodies and antigens have been widely used to manufacture rapid antigen and antibody tests. Many of them have received the EUA from the FDA.